252 related articles for article (PubMed ID: 25808170)
1. Current status of chemically synthesized inhibitors of Ebola virus.
Cardile AP; Mayers DL; Bavari S
Recent Pat Antiinfect Drug Discov; 2014; 9(2):97-103. PubMed ID: 25808170
[TBL] [Abstract][Full Text] [Related]
2. Will There Be a Cure for Ebola?
Cardile AP; Warren TK; Martins KA; Reisler RB; Bavari S
Annu Rev Pharmacol Toxicol; 2017 Jan; 57():329-348. PubMed ID: 27959624
[TBL] [Abstract][Full Text] [Related]
3. Infectious diseases. Ebola drug trials lurch ahead.
Kupferschmidt K; Cohen J
Science; 2015 Feb; 347(6223):701-2. PubMed ID: 25678637
[No Abstract] [Full Text] [Related]
4. Ebola Virus Infection: Review of the Pharmacokinetic and Pharmacodynamic Properties of Drugs Considered for Testing in Human Efficacy Trials.
Madelain V; Nguyen TH; Olivo A; de Lamballerie X; Guedj J; Taburet AM; Mentré F
Clin Pharmacokinet; 2016 Aug; 55(8):907-23. PubMed ID: 26798032
[TBL] [Abstract][Full Text] [Related]
5. Experimental Treatment with Favipiravir for Ebola Virus Disease (the JIKI Trial): A Historically Controlled, Single-Arm Proof-of-Concept Trial in Guinea.
Sissoko D; Laouenan C; Folkesson E; M'Lebing AB; Beavogui AH; Baize S; Camara AM; Maes P; Shepherd S; Danel C; Carazo S; Conde MN; Gala JL; Colin G; Savini H; Bore JA; Le Marcis F; Koundouno FR; Petitjean F; Lamah MC; Diederich S; Tounkara A; Poelart G; Berbain E; Dindart JM; Duraffour S; Lefevre A; Leno T; Peyrouset O; Irenge L; Bangoura N; Palich R; Hinzmann J; Kraus A; Barry TS; Berette S; Bongono A; Camara MS; Chanfreau Munoz V; Doumbouya L; Souley Harouna ; Kighoma PM; Koundouno FR; Réné Lolamou ; Loua CM; Massala V; Moumouni K; Provost C; Samake N; Sekou C; Soumah A; Arnould I; Komano MS; Gustin L; Berutto C; Camara D; Camara FS; Colpaert J; Delamou L; Jansson L; Kourouma E; Loua M; Malme K; Manfrin E; Maomou A; Milinouno A; Ombelet S; Sidiboun AY; Verreckt I; Yombouno P; Bocquin A; Carbonnelle C; Carmoi T; Frange P; Mely S; Nguyen VK; Pannetier D; Taburet AM; Treluyer JM; Kolie J; Moh R; Gonzalez MC; Kuisma E; Liedigk B; Ngabo D; Rudolf M; Thom R; Kerber R; Gabriel M; Di Caro A; Wölfel R; Badir J; Bentahir M; Deccache Y; Dumont C; Durant JF; El Bakkouri K; Gasasira Uwamahoro M; Smits B; Toufik N; Van Cauwenberghe S; Ezzedine K; D'Ortenzio E; Pizarro L; Etienne A; Guedj J; Fizet A; Barte de Sainte Fare E; Murgue B; Tran-Minh T; Rapp C; Piguet P; Poncin M; Draguez B; Allaford Duverger T; Barbe S; Baret G; Defourny I; Carroll M; Raoul H; Augier A; Eholie SP; Yazdanpanah Y; Levy-Marchal C; Antierrens A; Van Herp M; Günther S; de Lamballerie X; Keïta S; Mentre F; Anglaret X; Malvy D;
PLoS Med; 2016 Mar; 13(3):e1001967. PubMed ID: 26930627
[TBL] [Abstract][Full Text] [Related]
6. Recent progress on the treatment of Ebola virus disease with Favipiravir and other related strategies.
Zhang T; Zhai M; Ji J; Zhang J; Tian Y; Liu X
Bioorg Med Chem Lett; 2017 Jun; 27(11):2364-2368. PubMed ID: 28462833
[TBL] [Abstract][Full Text] [Related]
7. Favipiravir: a new medication for the Ebola virus disease pandemic.
Nagata T; Lefor AK; Hasegawa M; Ishii M
Disaster Med Public Health Prep; 2015 Feb; 9(1):79-81. PubMed ID: 25544306
[TBL] [Abstract][Full Text] [Related]
8. Anti-Ebola therapy for patients with Ebola virus disease: a systematic review.
Lee JS; Adhikari NKJ; Kwon HY; Teo K; Siemieniuk R; Lamontagne F; Chan A; Mishra S; Murthy S; Kiiza P; Hajek J; Bah EI; Lamah MC; Kao R; Fowler RA
BMC Infect Dis; 2019 May; 19(1):376. PubMed ID: 31046707
[TBL] [Abstract][Full Text] [Related]
9. Successful treatment of advanced Ebola virus infection with T-705 (favipiravir) in a small animal model.
Oestereich L; Lüdtke A; Wurr S; Rieger T; Muñoz-Fontela C; Günther S
Antiviral Res; 2014 May; 105():17-21. PubMed ID: 24583123
[TBL] [Abstract][Full Text] [Related]
10. INFECTIOUS DISEASE. As Ebola epidemic draws to a close, a thin scientific harvest.
Cohen J; Enserink M
Science; 2016 Jan; 351(6268):12-3. PubMed ID: 26721981
[No Abstract] [Full Text] [Related]
11. QTc interval prolongation during favipiravir therapy in an Ebolavirus-infected patient.
Chinello P; Petrosillo N; Pittalis S; Biava G; Ippolito G; Nicastri E;
PLoS Negl Trop Dis; 2017 Dec; 11(12):e0006034. PubMed ID: 29283993
[No Abstract] [Full Text] [Related]
12. Intracellular conversion and in vivo dose response of favipiravir (T-705) in rodents infected with Ebola virus.
Bixler SL; Bocan TM; Wells J; Wetzel KS; Van Tongeren SA; Garza NL; Donnelly G; Cazares LH; Soloveva V; Welch L; Epstein C; Liang LF; Giesing D; Lenk R; Bavari S; Warren TK
Antiviral Res; 2018 Mar; 151():50-54. PubMed ID: 29289664
[TBL] [Abstract][Full Text] [Related]
13. Experimental Treatment of Ebola Virus Disease with Brincidofovir.
Dunning J; Kennedy SB; Antierens A; Whitehead J; Ciglenecki I; Carson G; Kanapathipillai R; Castle L; Howell-Jones R; Pardinaz-Solis R; Grove J; Scott J; Lang T; Olliaro P; Horby PW;
PLoS One; 2016; 11(9):e0162199. PubMed ID: 27611077
[TBL] [Abstract][Full Text] [Related]
14. Ribavirin does not potentiate favipiravir antiviral activity against Ebola virus in non-human primates.
Madelain V; Duthey A; Mentré F; Jacquot F; Solas C; Lacarelle B; Vallvé A; Barron S; Barrot L; Mundweiler S; Thomas D; Carbonnelle C; Raoul H; de Lamballerie X; Guedj J
Antiviral Res; 2020 May; 177():104758. PubMed ID: 32135218
[TBL] [Abstract][Full Text] [Related]
15. Clinical and Virological Characteristics of Ebola Virus Disease Patients Treated With Favipiravir (T-705)-Sierra Leone, 2014.
Bai CQ; Mu JS; Kargbo D; Song YB; Niu WK; Nie WM; Kanu A; Liu WW; Wang YP; Dafae F; Yan T; Hu Y; Deng YQ; Lu HJ; Yang F; Zhang XG; Sun Y; Cao YX; Su HX; Sun Y; Liu WS; Wang CY; Qian J; Liu L; Wang H; Tong YG; Liu ZY; Chen YS; Wang HQ; Kargbo B; Gao GF; Jiang JF
Clin Infect Dis; 2016 Nov; 63(10):1288-1294. PubMed ID: 27553371
[TBL] [Abstract][Full Text] [Related]
16. [Current status of drug treatment against the disease caused by the Ebola virus].
Reina J
Rev Esp Quimioter; 2016 Feb; 29(1):1-7. PubMed ID: 26785224
[TBL] [Abstract][Full Text] [Related]
17. Development of Small-Molecule Antivirals for Ebola.
Janeba Z
Med Res Rev; 2015 Nov; 35(6):1175-94. PubMed ID: 26172225
[TBL] [Abstract][Full Text] [Related]
18. A 6-Year-Old Child with Severe Ebola Virus Disease: Laboratory-Guided Clinical Care in an Ebola Treatment Center in Guinea.
Palich R; Gala JL; Petitjean F; Shepherd S; Peyrouset O; Abdoul BM; Kinda M; Danel C; Augier A; Anglaret X; Malvy D; Blackwell N;
PLoS Negl Trop Dis; 2016 Mar; 10(3):e0004393. PubMed ID: 27011342
[No Abstract] [Full Text] [Related]
19. A dose of reality.
Cohen J; Kupferschmidt K
Science; 2014 Nov; 346(6212):908-11. PubMed ID: 25414285
[No Abstract] [Full Text] [Related]
20. Favipiravir for children with Ebola.
Bouazza N; Treluyer JM; Foissac F; Mentré F; Taburet AM; Guedj J; Anglaret X; de Lamballerie X; Keïta S; Malvy D; Frange P
Lancet; 2015 Feb; 385(9968):603-604. PubMed ID: 25706078
[No Abstract] [Full Text] [Related]
[Next] [New Search]
